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Abstract 
Objectives 
 
1. To adapt the existing German language olfactory disorders questionnaire for use with 
English-speaking patients 
2. To validate the adapted version for routine clinical use 
Design 
The translated version of the original German questionnaire was revised with a patient and a 
clinician to reflect British language and culture. Patients attending an olfactory dysfunction 
clinic were recruited to perform the adapted questionnaire on two occasions at least one 
month apart.  Additional online participants completed the questionnaire via the charity Fifth 
Sense. 
 
Main outcome measures 
 Re-test reliability of the English olfactory disorders questionnaire (eODQ) in affected 
patients including potential for redundancy in any of the included questions 
 Correlation of eODQ scores with Sniffin’ Sticks scores 
Results 
Eighty-seven patients reporting olfactory dysfunction were recruited and had a mean age of 
48 with 35% of them being male; 50 datasets were available for analysis. A total of 957 
members of the charity entered responses into the online questionnaire; 699 responses 
could be scored with participants’ mean age of 55 years and with 69% reporting as female.  
The eODQ score and Sniffin’ Sticks TDI score at timepoint 1 were correlated to assess for 
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concurrent validity, (r=-0.15, p=0.17) and showed no significant correlation. Female 
participants had a significantly higher mean total eODQ score than men, 55.75 compared to 
52.28 (p=0.001). The average score was 54.7 (SD 13.5) with a range from 26 to 87. The 
internal consistency of the questionnaire was good with a Cronbach’s alpha of 0.90 
(Confidence intervals 0.89, 0.91). 
 
Conclusions 
The results of this study support the use of the eODQ in a native English-speaking population 
and highlight the different distinctions between “objective” testing of olfaction with the 
Sniffin’ Sticks test and the patient reported impact of olfactory dysfunction on daily life. 
These two types of assessment can be easily administered in an outpatient setting and used 
in the assessment and management of olfactory dysfunction. 
 
Background 
Olfactory loss is an invisible condition with a prevalence in many studies estimated to vary 
from 1-20% 1-4, with the higher figures probably representing older patient populations 5, 
and with a recent study suggesting a distribution of 1-5% with anosmia4 and as high as 50% 
with hyposmia6. The lower figures do not include those who are unaware of their reduced 
olfactory capacity. Primary causes of olfactory loss include sinonasal disease (62%) and post-
viral olfactory loss (11%) 7 and other causes including head trauma and neurological disease. 
The sense of smell is an important and yet under-rated sense that many only appreciate 
once without it. It underwrites our interaction with the world in a mostly subconscious way 
but key overt usage is seen in the detection of danger such as a gas leak or spoiled food and 
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in those whose professions depend upon it such as firemen, chefs etc. It is also an important 
part of flavour perception, without which much of the pleasure of eating is gone. The 
spectrum of quality of life impact from olfactory disorders, is however, much broader with 
anxiety, depression and isolation common sequelae8.  The importance of carefully 
evaluating olfactory disorders has gained more recognition with the publication of the 
Position Paper of Olfactory Dysfunction9. This emphasises the need to evaluate patients’ 
olfactory performance beyond subjective reporting.  
However, psychophysical smell testing may not give additional insight into the impact of an 
olfactory disorder to the individual. A Questionnaire of Olfactory Disorders created by 
Frasnelli et al. in Germany was the first questionnaire that specifically addressed olfactory 
dysfunction and its daily life impact, consisting of statements of different domains of daily 
life that could be rated10.  Several studies have now utilised this questionnaire11-14 but it has 
yet to be validated in native English speaking participants. 
Aims and objectives 
This study aims to validate the Olfactory Disorders Questionnaire (ODQ) for English-speaking 
subjects (eODQ). 
Primary objective: 
 To assess the test-retest reliability of the adapted eODQ 
 
Secondary objectives: 
 To correlate quality of life impairment with psychophysical testing of olfaction 
 To assess the impact of patient contact (+/- intervention) on eODQ scores 
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Methods and Materials 
Ethical Considerations and Funding 
Ethical approval for the study was obtained from East of England - Cambridge East Research 
Ethics Committee (ref 14/EE/1010). The study was funded by a pump priming grant from 
the Otorhinolaryngological Research Society (now known as the British Otorhinolaryngology 
& Allied sciences Research Society (BOARS; www.entuk.org/about-boars). It received Clinical 
Research Network support from the National Institute of Health Research (CPMS ID: 16895).  
Settings 
The study was conducted in a tertiary care setting at the James Paget University Hospital 
and the Ipswich Hospital in East Anglia in the UK. It was also conducted online through 
membership of the patient support charity, Fifth Sense (www.fifthsense.org.uk), which was 
established in 2012 in the UK (Registered charity number 1175553.) The study was open 
between February 2014 and June 2015; however the final data capture point for online 
participants was 1st August 2017. 
Study design  
The original questionnaire (appendix 1) was anglicised by Philpott (clinician) and Boak 
(affected by olfactory disorder) to make it more culturally suited to native English speakers 
in the UK (see appendix 2). The questionnaire includes 24 questions (QoL score) assessing 
the respondent’s quality of life by asking them to rank their response with one of the 
following options: Agree, Agree partly, Disagree partly, Disagree, I think this question has no 
value, I don’t understand the question. The latter two response choices were added for 
validation purposes. Additional questions were added to rate symptoms (quantitative rating 
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score) and quality of life impact (QoL rating) using visual analogue scores giving a total 
maximum score out of 180. 
Phase 1 
As part of a larger study that included validation of the Sniffin’ Sticks for British subjects15, 
patients attending the Smell & Taste Clinic at the James Paget University Hospital and also 
at the Ipswich Hospital ENT Department who presented for routine clinical assessment with 
olfactory disorders were asked to participate in the study. Patient information leaflets were 
posted along with their appointment letter for the clinic. Previous clinic visitors were also 
invited by making the consent form available through the patient support charity Fifth 
Sense’s website (www.fifthsense.org.uk/research). Participants in this setting also 
underwent psychophysical olfactory testing with the Sniffin’ Sticks test. The “Sniffin’ Sticks” 
test uses pen-like odour dispensing devices to test odour threshold, odour discrimination 
and odour identification to produce a composite “TDI” score16. 
 
Phase 2 
The core questionnaire was also incorporated into a survey of members of Fifth Sense. The 
survey was designed to evaluate the severity of depression, anxiety, impairment of eating 
experiences, isolation, and relationship difficulties8. New members joining Fifth Sense were 
invited to complete an online anonymous survey regarding their quality of life with their 
disorder that included the adapted eODQ.  
Since the questionnaire was introduced to members, an additional free text question was 
subsequently added, asking respondents to name the cause of their olfactory loss; however 
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this information was not available for all online participants. No identifiable data was 
requested and as the survey was not conducted through an NHS or academic outlet, no 
ethical approval was sought for this specific component. 
Participants 
Inclusion criteria: 
 Subjects aged 18 years or over 
 Outpatient setting: Any patient reporting an olfactory disorder regardless of cause 
 Online setting: Any member of Fifth Sense self-reporting an olfactory disorder 
Exclusion criteria: 
 Subjects that did not understand the English language 
Variables 
For all hospital participants, data was recorded of their TDI scores for the extended Sniffin’ 
Sticks test along with their demographics and diagnosis and whether they had received any 
treatment between visits. Second clinic visits in phase 1 coincided with follow up clinic 
appointments. 
Data sources/management 
To record the results of the Sniffin’ Sticks test, the free “olaf” software download available 
from the Dresden Smell & Taste Clinic was used 10. Electronic health records were used to 
confirm details of the diagnosis. 
Sample Size 
No formal sample size calculation was made for the purposes of the study, however an 
indicative target of 100 patients with olfactory disorders from the clinics was set out at the 
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beginning of the study. With the online participants joining continuously during the study 
duration, a recent snapshot of data collected was taken to reflect active members of the 
charity. 
Statistical Methods 
Results were logged to a secure database and analysed with Stata/SE 14 (StataCorp. 2015. 
Stata Statistical Software: Release 14. College Station, Texas: StataCorp LP). The 
questionnaires were scored and before and after treatment comparisons made using t-
tests. The internal consistency of eODQ was assessed using Cronbach's alpha. 
Results 
Participants and descriptive data 
Phase 1. Hospital participants 
Eighty-seven patients reporting olfactory dysfunction were recruited from the two 
participating clinics and had a mean age of 47.5 (SD = 12.7) years with 35% of them being 
male. The aetiology of the 87 participants is characterised in table 1 and due to the nature 
of the wide geographic area from which participants came, the time interval between 
appointments varied between 3 and 12 months. 
 Phase 2. Online participants 
A total of 957 members of Fifth Sense entered responses into the online questionnaire. The 
respondents had an average age of 54.7 years (SD 13.0) ranging from 18 to 95 years old; 481 
(68.8%) were female.  Table 1 also shows the self-reported diagnoses of the respondents.  
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Outcome data 
A total of 86 hospital participants completed the eODQ scores on the first visit compared to 
66 on the second; a total of 50 people had observations at both time points. Of the total 957 
online responses, a total of 699 could be scored. The attrition was due to partially 
completed questionnaires or use of the 2 alternative responses (“I think this question has no 
value”, “I don’t understand the question”). In terms of aetiology, 425 participants self-
reported their presumed/confirmed diagnosis. 
Main Results 
Hospital participants (phase 1) 
Table 2 characterises the results for the 50 outpatient participants. This shows significant 
variation between visits. It was decided that breaking the data down into subgroups based 
on treatment or condition would not be appropriate due to the small sample size. When 
restricted to only individuals with no recorded treatment the same pattern remained. Table 
3 presents agreement measures between the timepoint and also restricted to only those on 
no treatment, these show poor agreement in the total quantitative score, total QoL rating 
score, and overall total, but reasonable agreement in the eODQ scores. The results do not 
depend greatly on the inclusion or exclusion of people on treatment.  
The eODQ score and Sniffin’ Sticks TDI score at timepoint 1 were correlated to assess for 
concurrent validity, (r=-0.15, p=0.17, table 4). These show no significant correlation 
between the two measures indicating that they are measuring something different. 
However, table 5 shows the correlation between the change in ODQ and the change in TDI 
components: there is a significant association between change in ODQ and discrimination, 
between TDI and its component scores and between threshold and discrimination. There 
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was no association between change in ODQ and change in total TDI score, change in 
threshold or change in identification. The association between change in ODQ and change in 
discrimination is shown graphically in Figure 1. 
Online participants (phase 2) 
Female participants had a significantly higher mean total ODQ score than men, 55.75 
compared to 52.28 (p=0.001) (Figure 2). The average score for all participants was 54.7 
(13.5) with a range from 26 to 87. The internal consistency of the questionnaire was good 
with a Cronbach’s alpha of 0.90 (Confidence Intervals 0.89, 0.91). The distribution of ODQ 
scores with age is shown in Figure 3 which showed no evidence of a correlation (r = - 0.06, 
p=0.12). In terms of question validity, 3 questions were identified with the highest 
responses for “I think this question has no value” or “I don’t understand this question” as 
demonstrated in Figure 4.  
 Q2: “My biggest problem is not that odours are less intense (or absent), but that things 
smell different from the way they used to”  - 105 participants did not value this question 
(11%) 
 Q5: “Food tastes different from what it used to” – 100 participants did not value this 
question (10%) 
 Q14: “Sometimes I have thoughts and ideas I would not want other people to know of” –  
115 participants did not value this question (12%) and 43 did not understand this 
question (4%) 
 Levels of apparent lack of understanding of questions were less than 2% with the 
exception of question 14. 
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The most well received question was Q4: “It reduces my appreciation of food and drink” 
where only 12 participants felt the question had no value and none of the participants failed 
to understand the question. 
 
Discussion 
Key Results 
Phase 1: 
Hospital participants completing the eODQ at the second visit in the clinic, reported a lower 
mean total eODQ score (p=0.0015). This suggests an improved score in those being seen 
back in the clinic, whether there had been any treatment instituted between visits or not. 
This reduction in score persists when those participants that did not undergo treatment 
between visits are analysed separately, p=0.0289. This suggests either spontaneous 
recovery has occurred or that the impact of visiting an olfactory dysfunction clinic can in 
itself change reported quality of life in those with olfactory dysfunction symptoms. This is 
also implied by the results that show poor correlation between Sniffin’ Sticks TDI score and 
the total eODQ score. This lack of correlation between the two tests indicates that they 
measure two different things and as such are affected by different variables, i.e., the Sniffin’ 
Sticks test is a psychophysical test and the eODQ is a patient reported health-related quality 
of life (HRQoL) questionnaire. It is notable that when looking at the change in score, 
discrimination, which is largely determined by higher cognitive influences17, correlated 
significantly with a change in the eODQ score. 
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The difference between subjective and objective olfactory dysfunction has been previously 
noted and explored. It can be shown that people with hyposmia on objective testing can 
report normal smell function and people with normal olfactory function on objective testing 
can have persistent poor QoL socres on questioning18. Similarly, people with hyposmia 
display poorer results on QoL questionnaires compared to people with complete anosmia19. 
This possibly reflects the lack of compensation in daily activates and lack of acceptance in 
those people with some persistent or fluctuating olfactory function. It should be noted 
though, that in other studies, a correlation between QoL testing and objective testing has 
been found. In 2009, Croy et al found a weak correlation between measured olfactory 
function and rated olfactory function20. Gudziol et al found a significant increase in the TDI 
scores of patients treated for hyposmia who stated their olfaction had improved, compared 
to those patients in the group who had stated that their olfaction was the same as before 
treatment21. The authors did note that there were some participants in the improved 
reported olfaction group that actually had a worse TDI score and some in the group that 
reported no change in olfactory function that had higher TDI scores. This also displays the 
variation in reported olfactory function and the difference in perceived function or QoL 
affected by olfactory dysfunction and the measured or objective olfactory function.  
Phase 2: 
When looking at the online questionnaire results, it can be seen that more women chose to 
complete the questionnaire than men, which may reflect the self-selecting nature of this 
group, either women report more olfactory dysfunction, have a higher symptom burden 
associated with olfactory dysfunction or the incidence in women is higher, which is known 
to be the case in post-viral olfactory loss. It has been shown before that women achieve 
higher scores than men in the threshold task of the Sniffin’Sticks test17 and that women 
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report a higher consequence of olfactory dysfunction than men20. Women have been shown 
to have lower HRQoL scores than men even after adjusting for age, race, marital status, 
education and income22. 
There were three questions for which the response “I think this question has no value” was 
given more frquently by the respondents completing the online questionnaire (figure 4). 
These questions were “My biggest problem is not that odours are less intense (or absent), 
but that things smell different from the way they used to”, “Food tastes different from what 
it used to” and “Sometimes I have thoughts and ideas I would not want other people to 
know of”. It may be surprising that a question asking about food elicits this response, 
however the first two of these questions are specific to parosmia sufferers so those without 
this distortion will perhaps not appreciate the relevance of them but it is nonetheless 
important to retain for those with qualitative disturbances. The last question was conceived 
in the original version as a “lie” question to be able to ascertain the quality of the answers 
given. Similar issues were noted in the study reported to validate the ODQ in a Korean 
population. So called sincerity questions were altered to suit a Korean language and 
culture11. Whilst our study does not support removing or altering these questions, it is 
noted that some respondents find these to be unusual or irrelevant in the subject of 
olfactory dysfunction, but they are very pertinent to those with qualitative disturbances23 
 
Limitations 
The second eODQ completed by participants in the clinic, was completed at follow up 
appointments. The nature of the clinic means that these participants travel to the clinic 
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from different areas of the country, this has led to variation in the time between both 
questionnaires being completed. This also led to fewer respondents completing the 
questionnaire for the second time as they were lost to follow up. 
We have not performed separate analysis of results based on diagnosis, treatment or main 
symptom; the difference in eODQ scores given by those suffering from parosmia or 
hyposmia is reported elsewhere9. For future reference it will be useful to provide a scaling 
for the test score, categorising the score as mild, moderate or severe. This will require 
further validation work which is beyond the scope of the data collected here but we will 
endeavour to undertake this accordingly in a new study. 
Generalisability 
The use of the eODQ has been shown to successfully assess the impact olfactory dysfunction 
has on a sufferers quality of life in other populations. We found similar patterns in response 
and gender bias as other studies9 and with the measures of consistency we have validated 
an easily administered questionnaire in an English-speaking population. 
Conclusion 
The results of this study support the use of the eODQ in a native English-speaking 
population and highlight the different distinctions between “objective” testing of olfaction 
with the Sniffin’ Sticks test and the patient reported impact of olfactory dysfunction on daily 
life. These two types of assessment can be easily administered in an outpatient setting and 
used in the assessment and management of olfactory dysfunction. Further research may 
allow for refinement of the questionnaire and stratification of severity into mild, moderate 
and severe. 
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List of abbreviations 
ODQ – Olfactory disorders questionnaire 
eODQ – English ODQ 
TDI – threshold, discrimination and identification 
QoL – quality of life 
 
Table 1: Aetiology of all participants 
 Hospital Participants Online Participants 
Diagnosis  Frequency Percentage Frequency Percentage 
CRS and subtypes  25 29% 58 14% 
Post-viral olfactory 
loss (PVOL) 
18 21% 119 28% 
Idiopathic  13 15% 78 18% 
Post-traumatic 
olfactory loss (PTOL)  
9 10% 82 19% 
Congenital 9 10% 25 6% 
Olfactory Cleft 
Disease 
6 7% - - 
Iatrogenic 3 3% 16 4% 
Nasal septal deviation 2 2% 6 1% 
Neoplasia - - 10 2% 
Parkinson’s Disease - - 15 4% 
Neurological - - 5 1% 
Diabetes - - 1 0.2% 
Granulomatosis with 
polyangiitis (GPA) 
  2 0.4% 
Presbyosmia   3 1% 
Toxic Rhinitis   5 1% 
other  2 2%   
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Table 2: Summary of differences between study visits in individuals with data at both 
timepoints. 
All subjects (n=50) Visit 1 Visit 2  
Outcome Mean (SD) Mean (SD) P-value 
Total QoL question score 54.18 (14.32) 49.30 (16.18) 0.0033 
Total quantitative score 17.10 (6.08) 14.34 (6.25) 0.0052 
Total QoL rating score 25.12 (10.01) 21.42 (13.66) 0.0414 
Total 96.40 (23.34) 85.06 (31.40) 0.0015 
Subjects with no treatment 
recorded (n=26) 
   
Total QoL question score 50.92 (13.01) 46.92 (16.18) 0.0345 
Total quantitative score 17.46 (5.37) 13.54 (6.69) 0.0059 
Total QoL rating score 23.77 (10.21) 19.85 (14.16) 0.1501 
Total 92.15 (22.76) 80.31 (33.39) 0.0289 
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Table 3: Measures of concordance/agreement between timepoints based on 
individuals who have data at both timepoints. 
Outcomes Lin Concordance  
(confidence intervals) 
ICC (confidence intervals) 
All subjects   
Total QoL question score 0.70 (0.56,0.83) 0.68 (0.54,0.77) 
Total quantitative score 0.38 (0.16,0.60) 0.38 (0.21,0.54) 
Total QoL rating score 0.44 (0.29,0.64) 0.41 (0.24,0.56) 
Total 0.58 (0.41,0.74) 0.56 (0.40,0.69) 
Subjects with no treatment   
Total QoL question score 0.78 (0.63,0.92) 0.77 (0.63,0.86) 
Total quantitative score 0.33 (0.04,0.62) 0.39 (0.15,0.59) 
Total QoL rating score 0.38 (0.08,0.69) 0.40 (0.16,0.60) 
Total 0.54 (0.30,0.78) 0.56 (0.34,0.71) 
 
 
Table 4: Correlation between TDI score and ODQ in hospital participants. 
Outcome Spearman correlation p-value 
Total QoL question score -0.12 0.28 
Total quantitative score -0.09 0.43 
Total QoL rating score -0.18 0.10 
Total -0.15 0.17 
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Table 5: Spearman Correlation between ODQ and TDI in hospital participants. Cells are 
correlation (r value) and significance (p-value) 
Variable ODQ TDI T D 
TDI -0.23 (0.12)    
T -0.03 (0.85) 0.71 (<0.0001)   
D -0.33 (0.02) 0.70 (<0.0001) 0.44 (0.0017)  
I -0.17 (0.26) 0.55 (0.0001) 0.10 (0.49) 0.15 (0.30) 
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Figures 
Figure 1: Correlation between the change in the eODQ scores and change in 
discrimination scores (hospital participants) 
 
Figure 2: Distribution of ODQ scores by gender (online participants) 
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Figure 3: Scatter graph of age against ODQ score (online participants) 
 
Figure 4: Frequency of responses where participants did not value or understand 
specific questions 
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Appendix 1: Original German version of ODQ in English 
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Appendix 2: Anglicised Olfactory Disorders Questionnaire (eODQ) 
 
Regarding your smell/taste 
disturbances: 
I agree I agree 
partly 
I 
disagree 
partly 
I 
disagree 
I don’t 
understand 
the 
question 
I think 
the 
question 
has no 
value 
1. Often I perceive a bad 
smell/taste*, regardless 
whether a potential 
odour/taste source is 
present 
 
* delete as appropriate 
      
2. My biggest problem is 
not that odours are less 
intense (or absent), but 
that things smell 
different from the way 
they used to 
      
3. I am aware of my 
problem all day long   
      
4. It reduces my       
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appreciation of food 
and drink 
5. Food tastes different 
from what it used to 
      
6. I now eat less than I 
used to 
      
7. I now eat less healthily 
than I used to 
      
8. I am now more careful 
about the food I eat 
      
9. I have gained (G) or lost 
(L) weight * delete as 
appropriate 
G/L* G/L*     
10. I go to restaurants less 
often than I used to 
      
11. I am wondering if I will 
ever be able to live with 
this problem 
      
12. I am more stressed than 
I used to be because of 
this problem 
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13. Sometimes I have 
thoughts and ideas I 
would not want other 
people to know of 
      
14. Most of my problems 
are due to the 
difficulties with my 
sense of smell 
      
15. I visit friends, relatives, 
or neighbours less often 
      
16. I find it harder to relax       
17. I can’t imagine adjusting 
to my difficulties with 
smelling  
      
18. The difficulties with my 
sense of smell make me 
feel alone and isolated 
      
19. I avoid groups of people       
20. This problem is just one of 
the many problems in life 
one has to live with 
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21. I am scared of getting 
exposed to certain 
dangers (e.g., gas, rotten 
food). 
      
22. I have problems taking 
part in many of the daily 
activities of life 
      
23. The difficulties with 
smelling make me feel 
angry and/or frustrated 
      
24. My relationship with my 
partner/family/friends is 
affected by my difficulties 
with smelling 
      
 
  From 
smell/taste 
loss? 
For other 
reason? 
25. Do you suffer with 
depression? 
Yes   
No   
26. Do you suffer with Yes   
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anxiety? No   
 
 
 
27. Please indicate with a circle around the score where you would place your symptoms 
today: 
 
a. Loss of sense of smell: 
 
No loss  0    1   2    3    4    5    6    7    8    9    10 Total loss (unable to 
smell) 
 
b. Loss of taste (referring only to sensations of salt, sweet, sour and bitter): 
 
No loss  0    1   2    3    4    5    6    7    8    9    10 Total loss (unable to 
taste) 
 
c. Nasal symptoms: 
 
 Normal   0    1   2    3    4    5    6    7    8    9    10 Stuffy, runny, etc  
 
d. Oral symptoms: 
 
 Normal   0    1   2    3    4    5    6    7    8    9    10 Sore, dry mouth etc 
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28. Please use the scale below to rate how annoying the difficulties with smelling/tasting are 
to you. 
 
    Not annoying            0    1   2    3    4    5    6    7    8    9    10 extremely  
  at all annoying  
 
 
29. Please use the scale below to rate how much it affects your enjoyment of food. 
  
 None of the time      0    1   2    3    4    5    6    7    8    9    10 all the time 
 
 
 
 
30. Please indicate on the scale below how severely the difficulties with smelling/tasting 
affected your professional performance during the last month.  
 
     Not at all                  0    1   2    3    4    5    6    7    8    9    10  extremely 
 
 
31. Please indicate on the scale below how severely the difficulties with smelling/tasting 
affected your recreational activities during the last month.  
 
    Not at all                  0    1   2    3    4    5    6    7    8    9    10  extremely 
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32. Please indicate on the scale below how severely the difficulties with smelling/tasting 
affected your private life during the last month.  
 
    Not at all                  0    1   2    3    4    5    6    7    8    9    10  extremely 
 
For doctor to complete: 
Total QoL question score                                     /100 
Total quantitative score (27 a+b+c):                                     /30 
Total QoL rating score (28-32):                                     /50 
Total OGDQ score:                                     /180 
 
 
